Navigation Links
Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results
Date:11/9/2009

Non-GAAP adjusted earnings per share- Diluted $0.28 (1) $0.30 (1) ===== ===== NET INCOME GAAP net income (loss) $34,940 $(144,374) Adjustments: Fair value write-up of acquired Third Wave inventory 83 3,933 Amortization of intangible assets acquired since fiscal 2006 51,805 31,968 Stock-based compensation associated with the termination of former Third Wave officers - 480 Operating charges relating to the closure of the Company's organic photoconductor drum coatings manufacturing operations in Shanghai and related costs 2,002 - Acquired in-process research and development - 195,200 Income tax effect primarily related to reconciling items (16,387)(2) (9,995)(3) ------- ------ Non-GAAP adjusted net income $72,443 $77,212 ======= ======= EBITDA Non-GAAP adjusted net income $72,443 Interest expense, net 16,283 Provision for income taxes 41,700 Depreciation and amortization not adjusted above 18,828 ------ Adjusted EBITDA $149,254 ======== EXPLANATORY NOTES: (1) Non-GAAP adjusted earnings per share was calculated based on 259,884 and 259,242 weighted average diluted shares outstanding for the three mont
'/>"/>
SOURCE Hologic, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

Related medicine technology :

1. Three Year Analysis of Treatment Efficacy, Cosmesis, and Toxicity Support use of the Hologic Mammosite Radiation Therapy System
2. ALS Therapy Development Institute Partners with Clinical Centers to Establish Pathological Mechanisms of Lou Gehrigs Disease
3. Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials
4. Paclitaxel Poliglumex (OPAXIO(TM)) Added to Cisplatin and Radiation Produces 45% Pathologic Complete Remissions in Patients With Esophageal Cancer
5. Clinical and Histopathological Results Using Pollogens TriPollar(TM) Radio Frequency Technology Published in the June Issue of the Journal of Cosmetic and Laser Therapy
6. Hologic Receives CE Marking for the ThinPrep(R) Integrated Imager
7. OPAXIO Produces High Rates of Pathologic Complete Remission in Patients with Advanced Esophageal Cancer; Study Paves Way for Potential Registration Trial as Radiation Sensitizer
8. Hologic Expands Healthcare Investment in Asia
9. Hologic to Host Investor Reception at RSNA 2009
10. Hologic to Present at Citis 2009 Sixth Annual Small/Mid Cap Conference
11. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... MINNEAPOLIS , July 23, 2014 ... they have added 14 new vendors so far ... Creekridge,s newest vendors are from both ... mid-size domestic organizations to large, well-known multi-national companies. ... Creekridge,s diversified suite of financing products including: standard ...
(Date:7/23/2014)... South Korea , July 23, 2014  Mezzion ... clinical program to evaluate the use of udenafil to ... for single ventricle heart defects. The clinical program will ... representatives of the Pediatric Heart Network (PHN), a multi-center ... and Blood Institute (NHLBI) of the National Institutes of ...
(Date:7/23/2014)... LONDON , July 23, 2014  Lightlake ... developing addiction treatments based on its expertise in ... an investigational new drug application ("IND") with respect ... Lightlake also announced today that it has received ... Drug Abuse ("NIDA"), part of the National Institutes ...
Breaking Medicine Technology:Creekridge Capital Signs Several New Vendor Partners 2Mezzion Pharma Initiates Clinical Development Program To Evaluate Udenafil In Adolescents With Single Ventricle Heart Defects 2Lightlake Therapeutics Inc. Files Investigational New Drug Application For Naloxone Nasal Spray For Reversing Opioid Overdose And Announces A Further Collaboration With The National Institute On Drug Abuse 2Lightlake Therapeutics Inc. Files Investigational New Drug Application For Naloxone Nasal Spray For Reversing Opioid Overdose And Announces A Further Collaboration With The National Institute On Drug Abuse 3
(Date:7/23/2014)... 2014 In its latest blog post, ... that having family close by during a stay in rehab ... process is successful, is focusing on a topic that is ... addiction-related dialogues: opiate abuse facts. , The Best Drug Rehabilitation ... An overview of opiates, and why they’re considered “the ...
(Date:7/23/2014)... (PRWEB) July 23, 2014 The Europe Drilling ... drilling fluid and completion fluid market in Europe with analysis ... market in Europe is estimated to grow from around $1.3 ... CAGR of 6.1%, for the given period. , Browse through ... Market Report, to get an idea of the in-depth analysis ...
(Date:7/23/2014)... 2014 AidJoy is delighted to announce that ... Zen on September 5, 2014 from 7:00 to 11:00 ... are expected to attend this semi-formal event. , "We are ... past six years," says Jess Dennis, Director of Operations and ... on this moment in AidJoy’s history before we launch into ...
(Date:7/23/2014)... 2014 "I wanted a better way to ... my blood sugar, blood pressure and pulse rate," said an ... have to carry along a bunch of different devices, so ... developed the Master III to make it easier to monitor ... convenient unit. The accessory enables the user to have more ...
(Date:7/23/2014)... shown that some high-profile athletes who suffered repeated blows ... clumps in their brains. Those clumps suggest the athletes ... scientists are working on tests that might be able ... an article in Chemical & Engineering News (C&EN) ... Society. , In the article, Lauren Wolf, a senior ...
Breaking Medicine News(10 mins):Health News:Latest Best Drug Rehabilitation Blog Post Focuses on Opiate Abuse Facts 2Health News:Europe Drilling Fluid & Completion Fluid Market is Expected to Reach $1.7 Billion in 2018 - New Report by MicroMarket Monitor 2Health News:Europe Drilling Fluid & Completion Fluid Market is Expected to Reach $1.7 Billion in 2018 - New Report by MicroMarket Monitor 3Health News:Europe Drilling Fluid & Completion Fluid Market is Expected to Reach $1.7 Billion in 2018 - New Report by MicroMarket Monitor 4Health News:Europe Drilling Fluid & Completion Fluid Market is Expected to Reach $1.7 Billion in 2018 - New Report by MicroMarket Monitor 5Health News:Europe Drilling Fluid & Completion Fluid Market is Expected to Reach $1.7 Billion in 2018 - New Report by MicroMarket Monitor 6Health News:AidJoy’s Inaugural Gala to be Held September 5, 2014 2
... clues to effects of aging, experts say , , THURSDAY, ... an important role in coordinating people,s circadian clocks and ... The circadian clock governs daily cycles of feeding, activity ... the Washington University School of Medicine said their finding ...
... more control of their high blood pressure (hypertension) when ... Dr. Ross D. Feldman, a clinical scientist with the ... recommends a simplified and more effective method of treating ... than multiple pills. The "Simplified Treatment Intervention to ...
... company cofounded by Beth Israel Deaconess Medical Center (BIDMC) ... has announced that it has closed an $8M Series ... Life Sciences (SVLS) and MedImmune Ventures. , The company ... T-cells, with their first program focusing on treatments for ...
... with the computer age comes the age of eye fatigue. ... at work or leisure), we develop a host of symptoms and ... ... sound familiar? Well, you are not alone. You ... The good news is that relief may be within your reach ...
... to Creating Realistic Development TimelinesRALEIGH, N.C., March 19 ... announces its Senior Vice President of Scientific and Medical ... site and country selection. The webinar will take place ... Thoelke will discuss how to mitigate one of the ...
... 19 The "Help is Here Express" bus tour ... 23-27 at various cities throughout the state in order ... programs that provide prescription medicines for free or nearly ... nine straight months, and having passed the national unemployment ...
Cached Medicine News:Health News:Internal Clock and Metabolism May Be Linked 2Health News:Biotech company cofounded by BIDMC scientists targets natural killer T-cells 2Health News:The Power of a Tiny Microscopic Plant Found To Reduce Computer Eye Strain 2Health News:PRA International Speaking Event: Beyond Global Feasibility 2Health News:Partnership for Prescription Assistance Prepared to Help Georgia Workers Hurt by Recession 2Health News:Partnership for Prescription Assistance Prepared to Help Georgia Workers Hurt by Recession 3Health News:Partnership for Prescription Assistance Prepared to Help Georgia Workers Hurt by Recession 4
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: